Skip to content
healthcare.dev

Evista

NDC 0002-4184, Raloxifene hydrochloride, tablet, from Eli Lilly and Company.

Product NDC
0002-4184
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020815
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4184 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RALOXIFENE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
0002-4184-300000241843030 TABLET in 1 BOTTLE (0002-4184-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9
  • NADAC price for package 00002418430

    GET /v1/drugs/nadac/00002418430

Use it

Look up 0002-4184 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4184 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-4184. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.